Inovio Pharmaceuticals (INO) Price to Book (2010 - 2026)

Inovio Pharmaceuticals has disclosed Price to Book across 17 years of filings, most recently posting 20.54 for Q2 2026.

• In Q2 2026, Price to Book rose 641.62% year-over-year to 20.54; the TTM figure through Jun 2026 stood at 20.54 (up 641.62% YoY), while the FY2025 annual figure was 3.39, up 366.62% from the prior year.
• Price to Book came in at 20.54 for Q2 2026 at Inovio Pharmaceuticals, down from 23.59 in the prior quarter.
• In the past five years, Price to Book ranged from a high of 23.59 in Q1 2026 to a low of 16.24 in Q3 2025.
• Average Price to Book over 5 years is 3.05, with a median of 1.69 recorded in 2022.
• Year-over-year, Price to Book plunged 891.58% in 2025 and jumped 1922.65% in 2026.
• Over 5 years, Price to Book stood at 1.78 in 2022, then sank by 33.05% to 1.19 in 2023, then slumped by 38.96% to 0.73 in 2024, then surged by 366.62% to 3.39 in 2025, then surged by 506.67% to 20.54 in 2026.
• Per Business Quant data, the three most recent Price to Book figures were 20.54 in Q2 2026, 23.59 in Q1 2026, and 3.39 in Q4 2025.